Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
ANGPTL2 was localized at lesion of laser-induced choroidal neovascularization in mice, and reduction of CNV volume and CNV-induced pro-inflammatory mediators were observed at ANGPTL2 deficient mice, indicating involvement of ANGPTL2 in CNV pathogenesis. In bone marrow transplantation model, both ANGPTL2 from retinal tissue and macrophage participated CNV development. In vitro study, phosphorylation of NF-κB and ERK1/2, acceleration of pro-inflammatory mediators, and macrophage migration were driven by recombinant ANGPTL2; suppressed by integrin α4 and/or β2 neutralizing antibody. ANGPTL2 and its signal induction might be new therapeutic target against age-related macular degeneration.
|